Zoetis Inc.

NYSE

Market Cap.

70.87B

Avg. Volume

3.04M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Zoetis Inc.

Zoetis Inc. News

Zoetis Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock
Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
zoetis.com

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Zoetis Inc. Earnings & Revenue

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Zoetis Inc. Financials

Table Compare

Compare ZTS metrics with:

   

Earnings & Growth

ZTS

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ZTS

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ZTS

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ZTS

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Zoetis Inc. Income

Zoetis Inc. Balance Sheet

Zoetis Inc. Cash Flow

Zoetis Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioSell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Zoetis Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.9320

Payment DateDividendFrequency
2025-09-030.5Quarterly
2025-06-030.5Quarterly
2025-03-040.5Quarterly
2024-12-030.432Quarterly
2024-09-040.432Quarterly

Historical Market Cap

Shares Outstanding

Zoetis Inc. Executives

NameRole
Ms. Kristin C. PeckChief Executive Officer & Director
Mr. Wetteny N. Joseph CPAExecutive Vice President & Chief Financial Officer
Mr. Jamie BrannanExecutive Vice President & Chief Commercial Officer
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development
Ms. Roxanne LaganoExecutive Vice President, General Counsel & Corporate Secretary
NameRoleGenderDate of BirthPay
Ms. Kristin C. PeckChief Executive Officer & DirectorFemale19714.46M
Mr. Wetteny N. Joseph CPAExecutive Vice President & Chief Financial OfficerMale19721.9M
Mr. Jamie BrannanExecutive Vice President & Chief Commercial OfficerMale19731.81M
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development19691.52M
Ms. Roxanne LaganoExecutive Vice President, General Counsel & Corporate SecretaryFemale19651.37M

Zoetis Inc. Insider Trades

Date3 Jun
NameLagano Roxanne
RoleExecutive Vice President
TransactionDisposed
TypeS-Sale
Shares652
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares1601
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares10029
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares5905
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares1601.4341
DateNameRoleTransactionTypeShares
3 JunLagano RoxanneExecutive Vice PresidentDisposedS-Sale652
21 MaySCULLY ROBERT WDirectorAcquiredM-Exempt1601
21 MaySCULLY ROBERT WDirectorAcquiredM-Exempt10029
21 MaySCULLY ROBERT WDirectorAcquiredM-Exempt5905
21 MaySCULLY ROBERT WDirectorDisposedM-Exempt1601.4341

Discover More

Streamlined Academy

Zoetis Inc.

NYSE

Market Cap.

70.87B

Avg. Volume

3.04M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Zoetis Inc. News

Zoetis Inc. Quantitative Score

Overall Score

Business

Growth

Unlock

Business

Quality

Unlock

Stock

Value

Unlock

Price

Move

Price

Momentum

Unlock

Price

Stability

Unlock

Zoetis Inc. Earnings & Revenue

Zoetis Inc. Income

Zoetis Inc. Balance Sheet

Zoetis Inc. Cash Flow

Zoetis Inc. Financials Over Time

Zoetis Inc. Executives

NameRole
Ms. Kristin C. PeckChief Executive Officer & Director
Mr. Wetteny N. Joseph CPAExecutive Vice President & Chief Financial Officer
Mr. Jamie BrannanExecutive Vice President & Chief Commercial Officer
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development
Ms. Roxanne LaganoExecutive Vice President, General Counsel & Corporate Secretary
NameRoleGenderDate of BirthPay
Ms. Kristin C. PeckChief Executive Officer & DirectorFemale19714.46M
Mr. Wetteny N. Joseph CPAExecutive Vice President & Chief Financial OfficerMale19721.9M
Mr. Jamie BrannanExecutive Vice President & Chief Commercial OfficerMale19731.81M
Dr. Robert J. Polzer Ph.D.Executive Vice President and President of Research & Development19691.52M
Ms. Roxanne LaganoExecutive Vice President, General Counsel & Corporate SecretaryFemale19651.37M

Zoetis Inc. Insider Trades

Date3 Jun
NameLagano Roxanne
RoleExecutive Vice President
TransactionDisposed
TypeS-Sale
Shares652
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares1601
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares10029
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares5905
Date21 May
NameSCULLY ROBERT W
RoleDirector
TransactionDisposed
TypeM-Exempt
Shares1601.4341
DateNameRoleTransactionTypeShares
3 JunLagano RoxanneExecutive Vice PresidentDisposedS-Sale652
21 MaySCULLY ROBERT WDirectorAcquiredM-Exempt1601
21 MaySCULLY ROBERT WDirectorAcquiredM-Exempt10029
21 MaySCULLY ROBERT WDirectorAcquiredM-Exempt5905
21 MaySCULLY ROBERT WDirectorDisposedM-Exempt1601.4341

Streamlined Academy

Website screenshot
HealthcareDrug Manufacturers - Specialty & Generic
zoetis.com

About Zoetis Inc.

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

AI Generated Qualitative Analysis

AI

Your time is precious, so save it. Use AI to get the most important information from the business.

Learn about Zoetis Inc.

What’s This Company Really Worth? Find Out Instantly.

Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.

Zoetis Inc. Financials

Table Compare

Compare ZTS metrics with:

   

Earnings & Growth

ZTS

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

ZTS

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

ZTS

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

ZTS

None

Debt/Assets Ratio

--

--

Assets/Liabilities Ratio

--

--

 

Zoetis Inc. Dividends

Yield (TTM)Dividend (TTM) 

Infinity%

1.9320

Payment DateDividendFrequency
2025-09-030.5Quarterly
2025-06-030.5Quarterly
2025-03-040.5Quarterly
2024-12-030.432Quarterly
2024-09-040.432Quarterly

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioStrong Sell
Price/Earnings RatioSell
Price/Book RatioStrong Sell

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More

The Secret to Analyzing Winning Stocks (Step-by-Step Examples Inside)